| 0 |
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
19 |
0.0004 |
| 1 |
Parenteral Iron Replacement [EPC] |
5 |
0.0004 |
| 2 |
Provitamin D2 Compound [EPC] |
10 |
0.0003 |
| 3 |
Aluminum Complex [EPC] |
6 |
0.0002 |
| 4 |
Vitamin D3 Analog [EPC] |
5 |
0.0002 |
| 5 |
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
5 |
0.0002 |
| 6 |
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] |
21 |
0.0002 |
| 7 |
CD52-directed Cytolytic Antibody [EPC] |
2 |
0.0001 |
| 8 |
Tissue-nonspecific Alkaline Phosphatase [EPC] |
1 |
0.0001 |
| 9 |
Nitroimidazole Antimicrobial [EPC] |
6 |
0.0001 |
| 10 |
Sodium-Glucose Cotransporter 2 Inhibitor [EPC] |
6 |
0.0001 |
| 11 |
Cytochrome P450 3A Inhibitor [EPC] |
3 |
0.0000 |
| 12 |
Carbonic Anhydrase Inhibitor [EPC] |
1 |
0.0000 |
| 13 |
Protease Inhibitor [EPC] |
2 |
0.0000 |
| 14 |
Calcium [EPC] |
5 |
0.0000 |
| 15 |
Osmotic Laxative [EPC] |
8 |
0.0000 |
| 16 |
HER2/neu Receptor Antagonist [EPC] |
2 |
0.0000 |
| 17 |
Dihydropyridine Calcium Channel Blocker [EPC] |
8 |
0.0000 |
| 18 |
Histamine-1 Receptor Antagonist [EPC] |
2 |
0.0000 |
| 19 |
Thiazide-like Diuretic [EPC] |
1 |
0.0000 |
| 20 |
Integrin Receptor Antagonist [EPC] |
2 |
0.0000 |
| 21 |
beta3-Adrenergic Agonist [EPC] |
1 |
0.0000 |
| 22 |
Aminosalicylate [EPC] |
2 |
0.0000 |
| 23 |
RANK Ligand Inhibitor [EPC] |
4 |
0.0000 |
| 24 |
Aldosterone Antagonist [EPC] |
3 |
0.0000 |
| 25 |
Angiotensin 2 Receptor Blocker [EPC] |
6 |
0.0000 |
| 26 |
Parathyroid Hormone Analog [EPC] |
2 |
0.0000 |
| 27 |
BCL-2 Inhibitor [EPC] |
1 |
0.0000 |
| 28 |
Janus Kinase Inhibitor [EPC] |
2 |
0.0000 |
| 29 |
Alkylating Drug [EPC] |
3 |
0.0000 |
| 30 |
Xanthine Oxidase Inhibitor [EPC] |
2 |
0.0000 |
| 31 |
Anti-IgE [EPC] |
1 |
0.0000 |
| 32 |
Dihydrofolate Reductase Inhibitor Antibacterial [EPC] |
1 |
0.0000 |
| 33 |
Nonsteroidal Anti-inflammatory Drug [EPC] |
13 |
0.0000 |
| 34 |
Interleukin-12 Antagonist [EPC] |
1 |
0.0000 |
| 35 |
Interleukin-23 Antagonist [EPC] |
1 |
0.0000 |
| 36 |
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 37 |
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] |
1 |
0.0000 |
| 38 |
alpha-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 39 |
Leukocyte Growth Factor [EPC] |
1 |
0.0000 |
| 40 |
Insulin Analog [EPC] |
3 |
0.0000 |
| 41 |
Microtubule Inhibitor [EPC] |
1 |
0.0000 |
| 42 |
Estrogen [EPC] |
1 |
0.0000 |
| 43 |
Expectorant [EPC] |
1 |
0.0000 |
| 44 |
Mood Stabilizer [EPC] |
1 |
0.0000 |
| 45 |
Anti-epileptic Agent [EPC] |
1 |
0.0000 |
| 46 |
Loop Diuretic [EPC] |
2 |
0.0000 |
| 47 |
Benzodiazepine [EPC] |
3 |
0.0000 |
| 48 |
Tumor Necrosis Factor Blocker [EPC] |
4 |
0.0000 |
| 49 |
Corticosteroid [EPC] |
5 |
0.0000 |
| 50 |
Factor Xa Inhibitor [EPC] |
1 |
0.0000 |
| 51 |
Platelet Aggregation Inhibitor [EPC] |
2 |
0.0000 |
| 52 |
Proton Pump Inhibitor [EPC] |
2 |
0.0000 |
| 53 |
beta-Adrenergic Blocker [EPC] |
1 |
0.0000 |
| 54 |
CD20-directed Cytolytic Antibody [EPC] |
1 |
0.0000 |
| 55 |
Vitamin C [EPC] |
1 |
0.0000 |
| 56 |
GLP-1 Receptor Agonist [EPC] |
1 |
0.0000 |